Top Wisconsin Biotech Startups (27)
Novir is a cutting-edge biotechnology company revolutionizing the way the world perceives and approaches healthcare. At Novir, we challenge the conventional care model by placing our focus on proactive measures rather than waiting for diagnoses. We firmly believe that care shouldn't start at diagnosis, but rather in the early stages of prevention. Our mission is to empower individuals to take...
Elephas is developing a technology platform to assess how live tumor cells respond to cancer therapies. We are harnessing the latest advances in cancer biology, multimodal microscopy, engineering, and artificial intelligence to revolutionize cancer treatment. Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Despite advances in precision medicine and a...
Cmxtwenty focuses on developing lipid compounds for use in non-narcotic pain treatment.
OUR MISSION: Empower Discovery. Enable Innovation. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and...
Bellbrook Labs is a research and development company focusing on advancing drug discovery for human health therapies.
Platypus Technologies develops analytical and life sciences products based upon the application of nanotechnology and materials science.
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion
Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.
Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.
EyeKor is a network of established reading centers and clinical trial experts.
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Capio Biosciences focuses on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes.
Ardelyx is a publicly traded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx's first approved product, IBSRELA® (tenapanor) is available in the United States. Ardelyx is developing XPHOZAH® (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed...
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical...
